Ticker
AEGIR.ST

Price
2.02
Stock movement up
+0.01 (0.60%)
Company name
Aegirbio AB
Exchange
(ST
,
Currency
SEK
)
Sector
Healthcare >
Medical Instruments & Supplies
Market cap
42.91M
Ent value
42.01M
Price/Sales
13.77
Price/Book
0.12
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-93.22%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2023-02-03

DIVIDENDS

AEGIR.ST does not pay dividends

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales13.77
Price to Book0.12
EV to Sales13.48

FINANCIALS

Per share

Loading...
Per share data
Current share count21.28M
EPS (TTM)-4.15
FCF per share (TTM)-5.91

Income statement

Loading...
Income statement data
Revenue (TTM)3.12M
Gross profit (TTM)1.56M
Operating income (TTM)-83.42M
Net income (TTM)-88.38M
EPS (TTM)-4.15
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)50.06%
Operating margin (TTM)-2677.05%
Profit margin (TTM)-2836.39%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash28.13M
Net receivables4.97M
Total current assets57.31M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets385.53M
Accounts payable0.00
Short/Current long term debt0.00
Total current liabilities11.92M
Total liabilities27.24M
Shareholder's equity358.29M
Net tangible assets33.97M

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-124.34M
Capital expenditures (TTM)1.54M
Free cash flow (TTM)-125.84M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-24.67%
Return on Assets-22.93%
Return on Invested Capital-24.67%
Cash Return on Invested Capital-35.12%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open2.00
Daily high2.02
Daily low1.95
Daily Volume111K
All-time high365.17
1y analyst estimate-
Beta3.50
EPS (TTM)-4.15
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
AEGIR.STS&P500
Current price drop from All-time high-99.45%-12.75%
Highest price drop-99.48%-56.47%
Date of highest drop20 Jan 20239 Mar 2009
Avg drop from high-60.28%-11.49%
Avg time to new high21 days13 days
Max time to new high388 days1805 days
COMPANY DETAILS
AEGIR.ST (Aegirbio AB) company logo
Marketcap
42.91M
Marketcap category
Small-cap
Description
AegirBio AB (publ), a diagnostic company, develops and commercializes tests for monitoring and optimizing the dosage of biological drugs Sweden and Asia. The company focuses on the neurology, cancer, and autoimmune diseases therapeutic areas. It offers moNATor, a first dose-monitoring laboratory test to test multiple sclerosis for healthcare professionals and patients; and Viraspec, a COVID-19 saliva test kit. AegirBio AB (publ) was incorporated in 2019 and is headquartered in Lund, Sweden.
Employees
17
Investor relations
-
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found